世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

米国 経皮的血管形成術用バルーンカテーテル(PTA)の市場レポート・予測 2021-2027年


United States Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Market Report & Forecast 2021-2027

当レポートでは、米国におけるPercutaneous Transluminal Angioplasty Balloon Catheter (PTA)の市場規模および予測を掲載しています。 米国 経皮経管的血管形成術バルーンカテーテル(PTA)市場収益、2016-2021... もっと見る

 

 

出版社 出版年月 電子版価格 言語
QYResearch
QYリサーチ
2021年11月12日 US$3,400
シングルユーザライセンス
ライセンス・価格情報・注文方法はこちら
英語

※当ページの内容はウェブ更新時の情報です。
最新版の価格やページ数などの情報についてはお問合せください。

日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。


 

サマリー

当レポートでは、米国におけるPercutaneous Transluminal Angioplasty Balloon Catheter (PTA)の市場規模および予測を掲載しています。
米国 経皮経管的血管形成術バルーンカテーテル(PTA)市場収益、2016-2021年、2022-2027年、(百万ドル)
アメリカ合衆国経皮経管的血管形成術バルーンカテーテル(PTA)市場販売数、2016-2021年、2022-2027年、(Kユニット)
米国 2020年における経皮的血管形成術バルーンカテーテル(PTA)の上位5社(%)について
経皮的血管形成バルーンカテーテル(PTA)の世界市場規模は、2020年のXX百万米ドルから2027年にはXX百万米ドルに成長すると予想され、2021年から2027年の間にXX%のCAGRで成長すると予想されています。
米国の経皮経管的血管形成術バルーンカテーテル(PTA)市場は、2020年にXX百万米ドルとなり、予測期間中にXX%のCAGRで2027年にXX百万米ドルに達すると予測されています。
QYResearchは、経皮経管的血管形成バルーンカテーテル(PTA)のメーカー、サプライヤー、流通業者、業界専門家を対象に、売上高、収益、需要、価格変動、製品タイプ、最近の開発・計画、業界動向、ドライバー、課題、障害、潜在的なリスクなど、この業界について調査しました。
総市場をセグメント別に見ると
米国経皮経管的血管形成術バルーンカテーテル(PTA)市場、タイプ別、2016-2021年、2022-2027年(単位:百万ドル)・(Kユニット)
米国経皮的血管形成術用バルーンカテーテル(PTA)市場セグメント別割合、タイプ別、2020年(%)
特殊PTAバルーンカテーテル
標準および高圧力PTAバルーンカテーテル

米国経皮経管的血管形成術バルーンカテーテル(PTA)市場、用途別、2016-2021年、2022-2027年(百万ドル)・(Kユニット)
米国経皮経管的血管形成術バルーンカテーテル(PTA)市場セグメント別割合、用途別、2020年(%)
病院
クリニック

競合他社の分析
本レポートでは、以下のような主要な市場参加者の分析も行っています。
主要企業 米国市場における経皮的血管形成術バルーンカテーテル(PTA)の収益、2016年~2021年(推定)、(百万ドル)
主要企業の米国市場における経皮的血管形成術バルーンカテーテル(PTA)の収益シェア、2020年(%)。
主要企業の米国市場における経皮的血管形成術用バルーンカテーテル(PTA)の売上高、2016-2021年(推定)、(Kユニット)
主要企業の米国市場における経皮的血管形成術用バルーンカテーテル(PTA)の売上高シェア、2020年(%)
さらに、本レポートでは、市場における競合他社のプロファイルを紹介しています。主要企業は以下の通りです。
ボストン・サイエンティフィック
メドトロニック
B. Braun
BD
アボット・ラボラトリーズ
テルモ
朝日インテック
メリット・メディカル・システムズ
カーディナルヘルス
amgインターナショナル社
バイオメトリクス
アコテック・サイエンティフィック・ホールディングス



ページTOPに戻る


目次

1 Introduction to Research & Analysis Reports
1.1 Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 United States Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year

2 United States Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Overall Market Size
2.1 United States Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Market Size: 2021 VS 2027
2.2 United States Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Revenue, Prospects & Forecasts: 2016-2027
2.3 United States Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Sales: 2016-2027

3 Company Landscape
3.1 Top Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Players in United States Market
3.2 Top United States Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Companies Ranked by Revenue
3.3 United States Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Revenue by Companies
3.4 United States Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Sales by Companies
3.5 United States Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Companies in United States Market, by Revenue in 2020
3.7 Manufacturers Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Product Type
3.8 Tier 1, Tier 2 and Tier 3 Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Players in United States Market
3.8.1 List of Tier 1 Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Companies in United States
3.8.2 List of Tier 2 and Tier 3 Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Companies in United States

4 Sights by Type
4.1 Overview
4.1.1 By Type - United States Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Market Size Markets, 2021 & 2027
4.1.2 Specialty PTA Balloons Catheter
4.1.3 Standard and High-Pressure PTA Balloons Catheter
4.2 By Type - United States Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Revenue & Forecasts
4.2.1 By Type - United States Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Revenue, 2016-2021
4.2.2 By Type - United States Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Revenue, 2022-2027
4.2.3 By Type - United States Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Revenue Market Share, 2016-2027
4.3 By Type - United States Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Sales & Forecasts
4.3.1 By Type - United States Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Sales, 2016-2021
4.3.2 By Type - United States Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Sales, 2022-2027
4.3.3 By Type - United States Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Sales Market Share, 2016-2027
4.4 By Type - United States Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Price (Manufacturers Selling Prices), 2016-2027

5 Sights by Application
5.1 Overview
5.1.1 By Application - United States Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Market Size, 2021 & 2027
5.1.2 Hospitals
5.1.3 Clinics
5.2 By Application - United States Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Revenue & Forecasts
5.2.1 By Application - United States Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Revenue, 2016-2021
5.2.2 By Application - United States Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Revenue, 2022-2027
5.2.3 By Application - United States Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Revenue Market Share, 2016-2027
5.3 By Application - United States Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Sales & Forecasts
5.3.1 By Application - United States Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Sales, 2016-2021
5.3.2 By Application - United States Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Sales, 2022-2027
5.3.3 By Application - United States Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Sales Market Share, 2016-2027
5.4 By Application - United States Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Price (Manufacturers Selling Prices), 2016-2027

6 Manufacturers & Brands Profiles
6.1 Boston Scientific
6.1.1 Boston Scientific Corporation Information
6.1.2 Boston Scientific Overview
6.1.3 Boston Scientific Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Sales and Revenue in United States Market (2016-2021)
6.1.4 Boston Scientific Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Product Description
6.1.5 Boston Scientific Recent Developments
6.2 Medtronic
6.2.1 Medtronic Corporation Information
6.2.2 Medtronic Overview
6.2.3 Medtronic Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Sales and Revenue in United States Market (2016-2021)
6.2.4 Medtronic Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Product Description
6.2.5 Medtronic Recent Developments
6.3 B. Braun
6.3.1 B. Braun Corporation Information
6.3.2 B. Braun Overview
6.3.3 B. Braun Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Sales and Revenue in United States Market (2016-2021)
6.3.4 B. Braun Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Product Description
6.3.5 B. Braun Recent Developments
6.4 BD
6.4.1 BD Corporation Information
6.4.2 BD Overview
6.4.3 BD Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Sales and Revenue in United States Market (2016-2021)
6.4.4 BD Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Product Description
6.4.5 BD Recent Developments
6.5 Abbott Laboratories
6.5.1 Abbott Laboratories Corporation Information
6.5.2 Abbott Laboratories Overview
6.5.3 Abbott Laboratories Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Sales and Revenue in United States Market (2016-2021)
6.5.4 Abbott Laboratories Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Product Description
6.5.5 Abbott Laboratories Recent Developments
6.6 Terumo
6.6.1 Terumo Corporation Information
6.6.2 Terumo Overview
6.6.3 Terumo Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Sales and Revenue in United States Market (2016-2021)
6.6.4 Terumo Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Product Description
6.6.5 Terumo Recent Developments
6.7 Asahi Intecc
6.7.1 Asahi Intecc Corporation Information
6.7.2 Asahi Intecc Overview
6.7.3 Asahi Intecc Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Sales and Revenue in United States Market (2016-2021)
6.7.4 Asahi Intecc Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Product Description
6.7.5 Asahi Intecc Recent Developments
6.8 Merit Medical Systems
6.8.1 Merit Medical Systems Corporation Information
6.8.2 Merit Medical Systems Overview
6.8.3 Merit Medical Systems Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Sales and Revenue in United States Market (2016-2021)
6.8.4 Merit Medical Systems Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Product Description
6.8.5 Merit Medical Systems Recent Developments
6.9 Cardinal Health
6.9.1 Cardinal Health Corporation Information
6.9.2 Cardinal Health Overview
6.9.3 Cardinal Health Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Sales and Revenue in United States Market (2016-2021)
6.9.4 Cardinal Health Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Product Description
6.9.5 Cardinal Health Recent Developments
6.10 amg International GmbH
6.10.1 amg International GmbH Corporation Information
6.10.2 amg International GmbH Overview
6.10.3 amg International GmbH Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Sales and Revenue in United States Market (2016-2021)
6.10.4 amg International GmbH Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Product Description
6.10.5 amg International GmbH Recent Developments
6.11 Biomerics
6.11.1 Biomerics Corporation Information
6.11.2 Biomerics Overview
6.11.3 Biomerics Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Sales and Revenue in United States Market (2016-2021)
6.11.4 Biomerics Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Product Description
6.11.5 Biomerics Recent Developments
6.12 Acotec Scientific Holdings
6.12.1 Acotec Scientific Holdings Corporation Information
6.12.2 Acotec Scientific Holdings Overview
6.12.3 Acotec Scientific Holdings Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Sales and Revenue in United States Market (2016-2021)
6.12.4 Acotec Scientific Holdings Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Product Description
6.12.5 Acotec Scientific Holdings Recent Developments

7 United States Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Production Capacity, Analysis
7.1 United States Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Production Capacity, 2016-2027
7.2 Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Production Capacity of Key Manufacturers in United States Market

8 Key Market Trends, Opportunity, Drivers and Restraints
8.1 Market Opportunities & Trends
8.2 Market Drivers
8.3 Market Restraints

9 Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Supply Chain Analysis
9.1 Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Industry Value Chain
9.2 Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Upstream Market
9.3 Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Downstream and Clients
9.4 Marketing Channels Analysis
9.4.1 Marketing Channels
9.4.2 Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Distributors and Sales Agents in United States Market

10 Conclusion
11 Appendix
11.1 Note
11.2 Examples of Clients
11.3 Author Details
11.4 Disclaimer

 

ページTOPに戻る


 

Summary

This report contains market size and forecasts of Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) in United States, including the following market information:
United States Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Market Revenue, 2016-2021, 2022-2027, ($ millions)
United States Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Market Sales, 2016-2021, 2022-2027, (K Units)
United States top five Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) companies in 2020 (%)
The global Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) market size is expected to growth from US$ XX million in 2020 to US$ XX million by 2027; it is expected to grow at a CAGR of XX% during 2021-2027.
The United States Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) market was valued at US$ XX million in 2020 and is projected to reach US$ XX million by 2027, at a CAGR of XX% during the forecast period.
QYResearch has surveyed the Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
United States Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K Units)
United States Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Market Segment Percentages, By Type, 2020 (%)
Specialty PTA Balloons Catheter
Standard and High-Pressure PTA Balloons Catheter

United States Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (K Units)
United States Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Market Segment Percentages, By Application, 2020 (%)
Hospitals
Clinics

Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) revenues in United States market, 2016-2021 (Estimated), ($ millions)
Key companies Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) revenues share in United States market, 2020 (%)
Key companies Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) sales in United States market, 2016-2021 (Estimated), (K Units)
Key companies Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) sales share in United States market, 2020 (%)
Further, the report presents profiles of competitors in the market, key players include:
Boston Scientific
Medtronic
B. Braun
BD
Abbott Laboratories
Terumo
Asahi Intecc
Merit Medical Systems
Cardinal Health
amg International GmbH
Biomerics
Acotec Scientific Holdings



ページTOPに戻る


Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 United States Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year

2 United States Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Overall Market Size
2.1 United States Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Market Size: 2021 VS 2027
2.2 United States Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Revenue, Prospects & Forecasts: 2016-2027
2.3 United States Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Sales: 2016-2027

3 Company Landscape
3.1 Top Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Players in United States Market
3.2 Top United States Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Companies Ranked by Revenue
3.3 United States Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Revenue by Companies
3.4 United States Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Sales by Companies
3.5 United States Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Companies in United States Market, by Revenue in 2020
3.7 Manufacturers Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Product Type
3.8 Tier 1, Tier 2 and Tier 3 Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Players in United States Market
3.8.1 List of Tier 1 Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Companies in United States
3.8.2 List of Tier 2 and Tier 3 Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Companies in United States

4 Sights by Type
4.1 Overview
4.1.1 By Type - United States Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Market Size Markets, 2021 & 2027
4.1.2 Specialty PTA Balloons Catheter
4.1.3 Standard and High-Pressure PTA Balloons Catheter
4.2 By Type - United States Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Revenue & Forecasts
4.2.1 By Type - United States Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Revenue, 2016-2021
4.2.2 By Type - United States Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Revenue, 2022-2027
4.2.3 By Type - United States Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Revenue Market Share, 2016-2027
4.3 By Type - United States Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Sales & Forecasts
4.3.1 By Type - United States Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Sales, 2016-2021
4.3.2 By Type - United States Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Sales, 2022-2027
4.3.3 By Type - United States Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Sales Market Share, 2016-2027
4.4 By Type - United States Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Price (Manufacturers Selling Prices), 2016-2027

5 Sights by Application
5.1 Overview
5.1.1 By Application - United States Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Market Size, 2021 & 2027
5.1.2 Hospitals
5.1.3 Clinics
5.2 By Application - United States Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Revenue & Forecasts
5.2.1 By Application - United States Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Revenue, 2016-2021
5.2.2 By Application - United States Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Revenue, 2022-2027
5.2.3 By Application - United States Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Revenue Market Share, 2016-2027
5.3 By Application - United States Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Sales & Forecasts
5.3.1 By Application - United States Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Sales, 2016-2021
5.3.2 By Application - United States Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Sales, 2022-2027
5.3.3 By Application - United States Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Sales Market Share, 2016-2027
5.4 By Application - United States Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Price (Manufacturers Selling Prices), 2016-2027

6 Manufacturers & Brands Profiles
6.1 Boston Scientific
6.1.1 Boston Scientific Corporation Information
6.1.2 Boston Scientific Overview
6.1.3 Boston Scientific Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Sales and Revenue in United States Market (2016-2021)
6.1.4 Boston Scientific Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Product Description
6.1.5 Boston Scientific Recent Developments
6.2 Medtronic
6.2.1 Medtronic Corporation Information
6.2.2 Medtronic Overview
6.2.3 Medtronic Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Sales and Revenue in United States Market (2016-2021)
6.2.4 Medtronic Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Product Description
6.2.5 Medtronic Recent Developments
6.3 B. Braun
6.3.1 B. Braun Corporation Information
6.3.2 B. Braun Overview
6.3.3 B. Braun Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Sales and Revenue in United States Market (2016-2021)
6.3.4 B. Braun Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Product Description
6.3.5 B. Braun Recent Developments
6.4 BD
6.4.1 BD Corporation Information
6.4.2 BD Overview
6.4.3 BD Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Sales and Revenue in United States Market (2016-2021)
6.4.4 BD Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Product Description
6.4.5 BD Recent Developments
6.5 Abbott Laboratories
6.5.1 Abbott Laboratories Corporation Information
6.5.2 Abbott Laboratories Overview
6.5.3 Abbott Laboratories Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Sales and Revenue in United States Market (2016-2021)
6.5.4 Abbott Laboratories Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Product Description
6.5.5 Abbott Laboratories Recent Developments
6.6 Terumo
6.6.1 Terumo Corporation Information
6.6.2 Terumo Overview
6.6.3 Terumo Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Sales and Revenue in United States Market (2016-2021)
6.6.4 Terumo Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Product Description
6.6.5 Terumo Recent Developments
6.7 Asahi Intecc
6.7.1 Asahi Intecc Corporation Information
6.7.2 Asahi Intecc Overview
6.7.3 Asahi Intecc Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Sales and Revenue in United States Market (2016-2021)
6.7.4 Asahi Intecc Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Product Description
6.7.5 Asahi Intecc Recent Developments
6.8 Merit Medical Systems
6.8.1 Merit Medical Systems Corporation Information
6.8.2 Merit Medical Systems Overview
6.8.3 Merit Medical Systems Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Sales and Revenue in United States Market (2016-2021)
6.8.4 Merit Medical Systems Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Product Description
6.8.5 Merit Medical Systems Recent Developments
6.9 Cardinal Health
6.9.1 Cardinal Health Corporation Information
6.9.2 Cardinal Health Overview
6.9.3 Cardinal Health Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Sales and Revenue in United States Market (2016-2021)
6.9.4 Cardinal Health Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Product Description
6.9.5 Cardinal Health Recent Developments
6.10 amg International GmbH
6.10.1 amg International GmbH Corporation Information
6.10.2 amg International GmbH Overview
6.10.3 amg International GmbH Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Sales and Revenue in United States Market (2016-2021)
6.10.4 amg International GmbH Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Product Description
6.10.5 amg International GmbH Recent Developments
6.11 Biomerics
6.11.1 Biomerics Corporation Information
6.11.2 Biomerics Overview
6.11.3 Biomerics Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Sales and Revenue in United States Market (2016-2021)
6.11.4 Biomerics Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Product Description
6.11.5 Biomerics Recent Developments
6.12 Acotec Scientific Holdings
6.12.1 Acotec Scientific Holdings Corporation Information
6.12.2 Acotec Scientific Holdings Overview
6.12.3 Acotec Scientific Holdings Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Sales and Revenue in United States Market (2016-2021)
6.12.4 Acotec Scientific Holdings Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Product Description
6.12.5 Acotec Scientific Holdings Recent Developments

7 United States Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Production Capacity, Analysis
7.1 United States Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Production Capacity, 2016-2027
7.2 Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Production Capacity of Key Manufacturers in United States Market

8 Key Market Trends, Opportunity, Drivers and Restraints
8.1 Market Opportunities & Trends
8.2 Market Drivers
8.3 Market Restraints

9 Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Supply Chain Analysis
9.1 Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Industry Value Chain
9.2 Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Upstream Market
9.3 Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Downstream and Clients
9.4 Marketing Channels Analysis
9.4.1 Marketing Channels
9.4.2 Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Distributors and Sales Agents in United States Market

10 Conclusion
11 Appendix
11.1 Note
11.2 Examples of Clients
11.3 Author Details
11.4 Disclaimer

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります


よくあるご質問


QYResearch社はどのような調査会社ですか?


QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。   QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/09/20 10:26

143.76 円

160.81 円

193.57 円

ページTOPに戻る